About us

Clínica Santa Clarita

Clinica Santa Clarita has been owned and operated by Grupo Atisa and/or its affiliates since 2000. Since its inception, Clinica Santa Clarita has dedicated itself to being a leader in both the medical and local communities. Prior to its recent remodeling, CSC specialized in general surgery. With 16 beds and over 1000 surgeries a year, CSC established itself as a leader in quality and service.

As a member of Grupo Atisa, CSC's most important achievement has been treating over 4,000 children for cleft palate and strabismus (crossed eyes) free of charge. Grupo Atisa strives to improve the lives of as many people as possible. By treating these simple conditions, the lives of many are greatly impacted. With the help of many organizations, including Mercy Hospital of San Diego and Fundacion Sara Barron, CSC has been able to join amazing doctors (in both talent and generosity) with patients in great need of their care.

Recently, adjusting to changing needs in the community and to position itself for the next 25 years, CSC has decided to focus on regenerative medicine. CSC has completely remodeled its facilities to serve as a research and treatment center. By focusing on stem cell research and treatment, CSC believes it is in a great position to once again leave its mark on the city of Tijuana.

In striving to do things the right way and most importantly, the sustainable way, CSC has focused intently on acquiring all the necessary permits and licenses needed to perform stem cell transplants and research. CSC is among the first facilities in Mexico to have both stem cell transplant and stem cell banking licenses issued by COFEPRIS, the Mexican equivalent of the FDA. With these licenses in hand CSC can transplant, import, research, sell, cultivate, and store stem cells. With these permits and new facilities, CSC hopes to open a new chapter in use and research of stem cells in both Mexico and the rest of the world.

In combination with its new facilities and permits, CSC has formed its own Ethics Board and Research Board. These boards have been approved by both COFEPRIS and the National Bioethics Committee, Mexico's highest authority regarding bioethics. The role of these independent boards is to monitor all research and transplant protocols. These boards have the highest authority at CSC, and it is they who approve CSC's activities.


Supported By

Grupo Atisa is a conglomerate of companies within the city of Tijuana. By focusing on real estate and construction in an era when the city of Tijuana has grown substantially, Grupo Atisa has established itself as a leader in both the business and philanthropic communities. CSC was acquired by Grupo Atisa in 2000 for the purpose of giving back to that community. For over 12 years and thousands of patients later, Grupo Atisa has dramatically improved the quality of life for its patients. By primarily focusing on simple to treat yet dramatically life changing procedures, Grupo Atisa has, in a sense, restored hope in thousands of families where hope was lost.

To continue its mission of improving the city of Tijuana and improving the life its community, Grupo Atisa has decided to focus CSC on stem cell research and treatment. Grupo Atisa sees great potential in stem cell technology and its ability to forever change the landscape of medicine. To continue its tradition of leadership, Grupo Atisa is working with Stemedica Cell Technologies to develop studies and treatment protocols. By having CSC and Stemedica working in unison, Grupo Atisa hopes to have created the perfect partnership and recipe for success.